SRT 1720 Hydrochloride is primarily used in scientific research to study cellular aging and metabolic regulation. It activates SIRT1, a protein involved in controlling cellular processes such as DNA repair, inflammation, and energy metabolism. Due to this activity, it is investigated for its potential role in extending cell lifespan and improving mitochondrial function.

Researchers use SRT 1720 Hydrochloride in studies related to age-related diseases, including type 2 diabetes, obesity, and neurodegenerative conditions. It has shown promise in preclinical models for improving insulin sensitivity and reducing fat accumulation in the liver. It is also explored for its protective effects in cardiovascular and neurological tissues under stress conditions.

Despite its research value, SRT 1720 Hydrochloride is not approved for clinical or therapeutic use in humans. Its application remains confined to laboratory settings for mechanistic studies and drug development pathways targeting sirtuin pathways.